- Home
- TFFP vs NURO Comparison
TFFP vs NURO Comparison
Compare TFFP & NURO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TFFP
- NURO
- Stock Information
- Founded
- TFFP 2018
- NURO 1996
- Country
- TFFP United States
- NURO United States
- Employees
- TFFP N/A
- NURO N/A
- Industry
- TFFP Biotechnology: Pharmaceutical Preparations
- NURO Medical/Dental Instruments
- Sector
- TFFP Health Care
- NURO Health Care
- Exchange
- TFFP Nasdaq
- NURO Nasdaq
- Market Cap
- TFFP 6.9M
- NURO 7.6M
- IPO Year
- TFFP 2019
- NURO N/A
- Fundamental
- Price
- TFFP $0.07
- NURO $3.86
- Analyst Decision
- TFFP Strong Buy
- NURO
- Analyst Count
- TFFP 1
- NURO 0
- Target Price
- TFFP $44.00
- NURO N/A
- AVG Volume (30 Days)
- TFFP 5.0M
- NURO 10.4K
- Earning Date
- TFFP 11-20-2024
- NURO 11-05-2024
- Dividend Yield
- TFFP N/A
- NURO N/A
- EPS Growth
- TFFP N/A
- NURO N/A
- EPS
- TFFP N/A
- NURO N/A
- Revenue
- TFFP $1,161,210.00
- NURO $3,767,764.00
- Revenue This Year
- TFFP $60.25
- NURO N/A
- Revenue Next Year
- TFFP N/A
- NURO N/A
- P/E Ratio
- TFFP N/A
- NURO N/A
- Revenue Growth
- TFFP 24.55
- NURO N/A
- 52 Week Low
- TFFP $0.06
- NURO $2.66
- 52 Week High
- TFFP $11.00
- NURO $4.73
- Technical
- Relative Strength Index (RSI)
- TFFP 20.20
- NURO 51.55
- Support Level
- TFFP $0.06
- NURO $3.63
- Resistance Level
- TFFP $0.31
- NURO $4.07
- Average True Range (ATR)
- TFFP 0.04
- NURO 0.24
- MACD
- TFFP 0.03
- NURO -0.03
- Stochastic Oscillator
- TFFP 1.12
- NURO 56.09
About TFFP TFF Pharmaceuticals Inc.
TFF Pharmaceuticals Inc is a biopharmaceutical company focused on developing and commercializing drug products based on its patented Thin Film Freezing, or TFF, technology platform. It is focused on the development of inhaled dry powder drugs for the treatment of lung disorders.
About NURO NeuroMetrix Inc.
NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.